Literature DB >> 17105758

Vasopressin antagonists--progress and promise.

Richard M Hays.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17105758     DOI： 10.1056/NEJMe068236

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Novel treatment targets for cerebral edema.

Authors:  Brian P Walcott; Kristopher T Kahle; J Marc Simard
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.

Authors:  Theresa Murphy; Rajat Dhar; Michael Diringer
Journal:  Neurocrit Care       Date:  2009-01-04       Impact factor: 3.210
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.